Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis

Hepatol Res. 2017 Mar;47(3):E178-E186. doi: 10.1111/hepr.12746. Epub 2016 Jul 21.

Authors

Tadashi Namisaki¹, Kei Moriya¹, Ryuichi Noguchi¹, Mitsuteru Kitade¹, Hideto Kawaratani¹, Junichi Yamao², Akira Mitoro¹, Motoyuki Yoshida¹, Masayoshi Sawai², Masakazu Uejima¹, Tsuyoshi Mashitani¹, Kosuke Takeda¹, Yasushi Okura², Kosuke Kaji¹, Hiroaki Takaya¹, Yosuke Aihara¹, Akitoshi Douhara¹, Norihisa Nishimura¹, Yasuhiko Sawada¹, Shinya Sato¹, Kenichiro Seki¹, Hitoshi Yoshiji¹

Affiliations

¹ Third Department of Internal Medicine, Nara Medical University, Kashihara, Japan.
² Department of Endoscopy and Ultrasound, Nara Medical University Hospital, Kashihara, Japan.

PMID: 27189879
DOI: 10.1111/hepr.12746

No abstract available

Keywords: bile duct loss; biochemical response to ursodeoxycholic acid; liver fibrosis; primary biliary cirrhosis.